Why is North Immunology pursuing a reverse merger for its dermatitis drug?

North Immunology is using a reverse merger as a financing strategy tied to advancing its atopic dermatitis drug into the clinic. The article says the key unknowns are the merger partner, available cash, and whether the combined company will have enough runway to hit early clinical milestones.